344
Participants
Start Date
March 31, 2002
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Ziprasidone
20mg capsules BID, 40mg capsules BID, 60mg BID or 80mg BID until drug commercialisation in Italy.
Pfizer Investigational Site, Orbassano, to
Pfizer Investigational Site, Rivoli, to
Pfizer Investigational Site, Torino
Pfizer Investigational Site, Torino
Pfizer Investigational Site, Cuneo
Pfizer Investigational Site, Genova
Pfizer Investigational Site, Genova
Pfizer Investigational Site, Genova
Pfizer Investigational Site, Passirana Di Rho (Mi)
Pfizer Investigational Site, Monza MI
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Chiari (Bs)
Pfizer Investigational Site, Melzo (MI)
Pfizer Investigational Site, Cremona
Pfizer Investigational Site, Pavia
Pfizer Investigational Site, Arona (No)
Pfizer Investigational Site, Portogruaro (Ve)
Pfizer Investigational Site, Dolo (Ve)
Pfizer Investigational Site, Montebelluna (TV)
Pfizer Investigational Site, Treviso
Pfizer Investigational Site, Udine
Pfizer Investigational Site, Pordenone
Pfizer Investigational Site, Padua
Pfizer Investigational Site, Bassano del Grappa
Pfizer Investigational Site, Montecchio Maggiore (VI)
Pfizer Investigational Site, Verona
Pfizer Investigational Site, Merano (BZ)
Pfizer Investigational Site, Bolzano
Pfizer Investigational Site, San Giorgio Di Piano BO
Pfizer Investigational Site, Casalecchio Di Reno BO
Pfizer Investigational Site, Bologna
Pfizer Investigational Site, Bologna
Pfizer Investigational Site, Parma
Pfizer Investigational Site, Cesena FO
Pfizer Investigational Site, Empoli
Pfizer Investigational Site, Montevarchi (AR)
Pfizer Investigational Site, Arezzo
Pfizer Investigational Site, Viareggio
Pfizer Investigational Site, Pisa
Pfizer Investigational Site, Livorno
Pfizer Investigational Site, Senigallia, AN
Pfizer Investigational Site, Fano (PS)
Pfizer Investigational Site, San Benedetto Del Tronto, AP
Pfizer Investigational Site, Guardiagrele (CH)
Pfizer Investigational Site, L’Aquila
Pfizer Investigational Site, Bisceglie (BA)
Pfizer Investigational Site, San Marco in Lamis FG
Pfizer Investigational Site, Brindisi
Pfizer Investigational Site, Lecce
Pfizer Investigational Site, Taranto
Pfizer Investigational Site, Matera
Pfizer Investigational Site, Frattaminore (NA)
Pfizer Investigational Site, Napoli
Pfizer Investigational Site, Caserta
Pfizer Investigational Site, Puglianello (BN)
Pfizer Investigational Site, Nocera Inferiore, SA
Pfizer Investigational Site, Sant'Arsenio (SA)
Pfizer Investigational Site, Salerno
Pfizer Investigational Site, Acri, CS
Pfizer Investigational Site, Lamezia Terme
Pfizer Investigational Site, Crotone
Pfizer Investigational Site, Reggio Calabria
Pfizer Investigational Site, Cefalu' (Pa)
Pfizer Investigational Site, Partinico (Pa)
Pfizer Investigational Site, Palermo
Pfizer Investigational Site, Palermo
Pfizer Investigational Site, Palermo
Pfizer Investigational Site, Enna
Pfizer Investigational Site, Giarre, CT
Pfizer Investigational Site, Catania
Pfizer Investigational Site, Noto
Pfizer Investigational Site, Ragusa
Pfizer Investigational Site, Sora
Pfizer Investigational Site, Cagliari
Pfizer Investigational Site, Formia (LT)
Pfizer Investigational Site, Genzano (RM)
Pfizer Investigational Site, Novi Ligure, AL
Pfizer Investigational Site, Spoleto (PG)
Pfizer Investigational Site, Perugia
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Sassari
Pfizer Investigational Site, Tivoli (RM)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY